Comparing efficacy and safety of tocilizumab and methylprednisolone in the treatment of patients with severe COVID-19

OBJECTIVES: This study was designed to compare the efficacy and safety of methylprednisolone and tocilizumab in the treatment of patients with severe COVID-19. METHODS: During a prospective cohort study, hospitalized patients with severe COVID-19 received intravenous methylprednisolone (250–500 mg d...

Descripción completa

Detalles Bibliográficos
Autores principales: Abbasian, Ladan, Toroghi, Negar, Rahmani, Hamid, Khalili, Hossein, Hasannezhad, Malihe, Ghiasvand, Fereshteh, Jafari, Sirous, Salehi, Mohammadreza, Salahshour, Faeze, Azadbakhsh Kanaf Gorabi, Mahsa, Alizade, Fateme, Ghaderkhani, Sara, Nakhostin, Maryam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8929537/
https://www.ncbi.nlm.nih.gov/pubmed/35313272
http://dx.doi.org/10.1016/j.intimp.2022.108689

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8929537/
https://www.ncbi.nlm.nih.gov/pubmed/35313272
http://dx.doi.org/10.1016/j.intimp.2022.108689

Ejemplares similares